BIIB023 (Anti-TWEAK) in Subjects With Rheumatoid Arthritis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2008
Phase I study designed to determine the safety and tolerability of a single dose of BIIB023 administered intravenously versus placebo to subjects with RA.
Epistemonikos ID: 2ea602ac24a0566615555721ad2a988611eb44e9
First added on: Mar 23, 2022